Update on HIV-BLA-PDUFA: FDA requested more information to complete a substantive review. No additional trials required. CytoDyn plans to submit the requested information and will ask for a Type A meeting with the FDA per the agency’s suggestion Jul 13, 2020 6:00am EDT
CytoDyn to Present at Wall Street Reporter’s Livestream Event on July 9, 2020 at 1:30 pm ET / 10:30 am PT Jul 08, 2020 5:34pm EDT
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution and Supply of Leronlimab for Treatment of COVID-19 in United States Jul 06, 2020 6:00am EDT
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution and Supply of Leronlimab for Treatment of COVID-19 in United States Jul 03, 2020 6:15pm EDT
CytoDyn Releases Mechanism of Action Animation for Leronlimab in Immuno-Oncology Jul 02, 2020 6:00am EDT
CytoDyn and NIH of Mexico Complete Memorandum of Understanding to Conduct Small Covid-19 Phase 3 Trial for Severe and Critically Ill Patients Jun 29, 2020 6:00am EDT
CytoDyn Initiates Phase 2 Clinical Trial With Leronlimab for Treatment of NASH Jun 11, 2020 6:59pm EDT
